Diseases, Conditions, Syndromes

Recombinant vaccine confers more protection against influenza

A high-dose recombinant influenza vaccine is more effective than standard-dose vaccine among adults aged 50 to 64 years, according to a study published in the Dec. 14 issue of the New England Journal of Medicine.

Immunology

Researchers find a clue to fighting fatal influenza

When influenza (or flu) reaches the critical stage, there are no specific treatments available for patients. Now new research has identified a key to this sometimes fatal condition, and opened the door to possible cures.

Diseases, Conditions, Syndromes

How worried should we be about the pneumonia outbreak in China?

Reports of a surge in pneumonia-like illness primarily affecting children in northern China have captured our attention. The last time we heard about a mysterious respiratory outbreak leading to overcrowding in hospitals ...

page 3 from 40